FMR LLC and Abigail P. Johnson filed a Schedule 13G with the SEC on November 4, 2026, disclosing beneficial ownership of common stock in Amer Sports Inc. as of September 30, 2026.
FMR LLC and Abigail P. Johnson filed an amended beneficial ownership statement with the SEC on November 5, 2026, disclosing a combined stake of approximately 2.6% in Abercrombie & Fitch Co. Class A Common Stock as of September 30, 2026.
FMR LLC and Abigail P. Johnson filed Amendment No. 2 to a Schedule 13G with the SEC on November 4, 2026, disclosing beneficial ownership of Bio-Techne Corp common stock as of September 30, 2026.
FMR LLC and Abigail P. Johnson filed Amendment No. 16 to a Schedule 13G with the SEC on November 4, 2026, disclosing beneficial ownership of common stock in Amdocs Limited as of September 30, 2026.
FMR LLC and Abigail P. Johnson filed an amended beneficial ownership statement with the SEC on November 4, 2026, disclosing a combined 7.7% interest in Smartbird Inc.'s Class A Common Stock as of September 30, 2026.
FMR LLC and Abigail P. Johnson filed Amendment No. 7 to a Schedule 13G with the SEC on November 4, 2026, disclosing beneficial ownership of common stock in Annexon Inc as of September 30, 2026.
FMR LLC and Abigail P. Johnson filed an amended beneficial ownership statement with the SEC on November 5, 2026, disclosing aggregate holdings of 11,032,007.32 shares of Alcoa Corp common stock as of September 30, 2026.
FMR LLC filed Amendment No. 13 to its Schedule 13G with the SEC on November 4, 2026, disclosing beneficial ownership of common stock in Ascendis Pharma A/S as of September 30, 2026.
FMR LLC filed an amended beneficial ownership statement with the SEC on November 5, 2026, disclosing a 7.5 percent stake in Adeia Inc, a technology licensing company headquartered in San Jose, California, as of the September 30, 2026 event date.
FMR LLC and Abigail P. Johnson filed Amendment No. 13 to their beneficial ownership statement with the SEC on November 5, 2026, disclosing a combined 9.9% interest in the common stock of argenx SE as of September 30, 2026.